PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.
Caterina De RosaFrancesca IommelliViviana De RosaGiuseppe ErcolanoFederica SodanoConcetta TuccilloLuisa AmatoVirginia TirinoAnnalisa ArianoFlora CimminoGaetano di GuidaGennaro FilosaAlessandra di LielloDavide CiardielloErika MartinelliTeresa TroianiStefania NapolitanoGiulia MartiniFortunato CiardielloFederica PapaccioFloriana MorgilloCarminia Maria Della CortePublished in: Biomedicines (2024)
cGAS-STING signaling activation in PBMCs may be a novel potential predictive biomarker for the response to immunotherapy and high levels are correlated with a better response to treatment along with an overall increased antitumor immune injury.
Keyphrases